UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2944) 2944
Book Chapter (17) 17
Dissertation (17) 17
Publication (4) 4
Web Resource (4) 4
Magazine Article (2) 2
Book Review (1) 1
Conference Proceeding (1) 1
Newspaper Article (1) 1
Paper (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
meropenem (2662) 2662
science & technology (1846) 1846
life sciences & biomedicine (1689) 1689
humans (1268) 1268
infectious diseases (853) 853
microbiology (850) 850
antibiotics (820) 820
pharmacology & pharmacy (767) 767
microbial sensitivity tests (613) 613
anti-bacterial agents - pharmacology (575) 575
imipenem (560) 560
male (557) 557
biological and medical sciences (545) 545
medical sciences (519) 519
female (505) 505
drug resistance (497) 497
pharmacology. drug treatments (435) 435
bacteria (430) 430
thienamycins - pharmacology (429) 429
antibacterial agents (424) 424
antimicrobial agents (370) 370
antibiotics. antiinfectious agents. antiparasitic agents (369) 369
anti-bacterial agents - therapeutic use (357) 357
middle aged (354) 354
infections (341) 341
adult (333) 333
aged (322) 322
carbapenems (305) 305
thienamycins - therapeutic use (283) 283
hospitals (278) 278
patients (264) 264
biochemical phenomena, metabolism, and nutrition (250) 250
pseudomonas aeruginosa (239) 239
pathogens (235) 235
carbapenems - pharmacology (232) 232
ceftazidime (231) 231
bacterial infections and mycoses (230) 230
e coli (228) 228
antibiotic resistance (227) 227
anti-bacterial agents - administration & dosage (223) 223
polycyclic compounds (211) 211
thienamycins - administration & dosage (206) 206
treatment outcome (206) 206
ciprofloxacin (205) 205
colistin (200) 200
pneumonia (199) 199
piperacillin (192) 192
pseudomonas aeruginosa - drug effects (191) 191
imipenem - pharmacology (189) 189
analysis (182) 182
drug resistance in microorganisms (182) 182
mortality (182) 182
antimicrobial resistance (179) 179
minimum inhibitory concentration (178) 178
cefepime (177) 177
amikacin (175) 175
carbapenemase (175) 175
health aspects (175) 175
laboratories (174) 174
vancomycin (174) 174
animals (171) 171
medicine (170) 170
pharmacokinetics (167) 167
ertapenem (166) 166
tazobactam (165) 165
thienamycins - pharmacokinetics (161) 161
beta-lactamases - metabolism (155) 155
beta-lactamases - genetics (153) 153
klebsiella (152) 152
research article (152) 152
gram-negative bacteria (145) 145
anti-bacterial agents - pharmacokinetics (139) 139
drug resistance, bacterial (137) 137
genes (136) 136
risk factors (136) 136
adolescent (135) 135
immunology (135) 135
research (134) 134
aged, 80 and over (132) 132
beta lactam antibiotics (131) 131
nosocomial infections (131) 131
clinical isolates (130) 130
science & technology - other topics (130) 130
epidemiology (129) 129
multidisciplinary sciences (129) 129
internal medicine (128) 128
bacterial infections (127) 127
ampicillin (124) 124
pharmacology (124) 124
meropenem - pharmacology (123) 123
multidrug resistance (123) 123
gentamicin (122) 122
carbapenem (121) 121
infection (121) 121
sepsis (119) 119
drug therapy, combination (118) 118
antiinfectives and antibacterials (116) 116
science (116) 116
pediatrics (115) 115
polymerase chain reaction (114) 114
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2842) 2842
Japanese (52) 52
Chinese (49) 49
Spanish (36) 36
Portuguese (27) 27
German (24) 24
French (11) 11
Turkish (11) 11
Italian (8) 8
Russian (7) 7
Slovak (7) 7
Polish (3) 3
Czech (2) 2
Belarusian (1) 1
Croatian (1) 1
Hungarian (1) 1
Indonesian (1) 1
Persian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical therapeutics, ISSN 0149-2918, 04/2020, Volume 42, Issue 4, pp. 692 - 702
carbapenemase-producing organisms | Klebsiella pneumonia carbapenemase | meropenem-vaborbactam | vaborbactam | multidrug-resistant gram-negative organisms | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Heterocyclic Compounds, 1-Ring - pharmacokinetics | Humans | Boronic Acids - adverse effects | Meropenem - adverse effects | Boronic Acids - chemistry | Meropenem - administration & dosage | Heterocyclic Compounds, 1-Ring - administration & dosage | Drug Interactions | Heterocyclic Compounds, 1-Ring - chemistry | Anti-Bacterial Agents - chemistry | Anti-Bacterial Agents - pharmacokinetics | Boronic Acids - pharmacokinetics | Heterocyclic Compounds, 1-Ring - adverse effects | Meropenem - pharmacokinetics | Anti-Bacterial Agents - adverse effects | Boronic Acids - administration & dosage | Meropenem - chemistry | Anti-Bacterial Agents - administration & dosage | Drug Combinations | Drug resistance in microorganisms | Pneumonia | Bacterial infections | Tazobactam | Bacterial pneumonia | Beta lactamases | Urinary tract infections | Permeability | Drug approval | Klebsiella | Enterobacter cloacae | Hemodialysis | Clinical trials | Carbapenemase | Organisms | Infections | Urinary tract | Drug resistance | Chloride | Bacterial diseases | E coli | Piperacillin | Bacteria | Pseudomonas aeruginosa | Meropenem | Drug dosages | Efflux | Enzymes | Pharmacodynamics | Drug interactions | Piperacillin-tazobactam | Pharmacology | FDA approval | Bacteremia | Chemotherapy | Acids | Antibiotics | Pyelonephritis | Minimum inhibitory concentration | Skin | Renal replacement therapy | Pharmacokinetics | Index Medicus
Journal Article
The New England journal of medicine, ISSN 0028-4793, 02/2019, Volume 380, Issue 8, pp. 729 - 740
Journal Article